Katell Le Lay is a seasoned professional in HEOR and RWE with a strong background in developing stakeholder-relevant evidence and leading market access strategies. They served as the Global HEOR Manager at Pierre Fabre from 2007 to 2011, where they developed public health and health economic programs. Following their role at Boehringer Ingelheim France, where they managed market access strategies from 2010 to 2015, they became the Directeur unité médico-économie at Roche in 2022. Katell has demonstrated leadership by building collaborative partnerships and managing teams, and they hold degrees from Université de Rennes I, University of York, and further training at McGill University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices